Table 1. List of peptides used in study.
Peptide name | Peptide sequence | AA residues: arginine residues | Net peptide charge at pH 7 |
---|---|---|---|
R1 | H-R-OH | 1: 1 | 1 |
R3 | H-RRR-OH | 3: 3 | 3 |
R6 | H-RRRRRR-OH | 6: 6 | 6 |
R7 | H-RRRRRRR-OH | 7: 7 | 7 |
R8 | H-RRRRRRRR-OH | 8: 8 | 8 |
R9 | H-RRRRRRRRR-OH | 9: 9 | 9 |
R9D | H-rrrrrrrrr-NH2 | 9: 9 | 10 |
R10 | H-RRRRRRRRRR-OH | 10: 10 | 10 |
R11 | H-RRRRRRRRRRR-OH | 11: 11 | 11 |
R12 | H-RRRRRRRRRRRR-OH | 12: 12 | 12 |
R13 | H-RRRRRRRRRRRRR-OH | 13: 13 | 13 |
R14 | H-RRRRRRRRRRRRRR-OH | 14: 14 | 14 |
R15 | H-RRRRRRRRRRRRRRR-OH | 15: 15 | 15 |
R18 | H-RRRRRRRRRRRRRRRRRR-OH | 18: 18 | 18 |
R9/X7/R9 | H-RRRRRRRRRPGRVVGGRRRRRRRRR-OH | 25: 19 | 19 |
E9/R9 | H-EEEEEEEEE-RRRRRRRRR-OH | 18: 9 | 0 |
K10 | H-KKKKKKKKKK-OH | 10: 0 | 10 |
PTD-4a | H-YARAAARQARA-OH | 11: 3 | 3 |
TAT | Ac-GRKKRRQRRRG-NH2 | 11: 6 | 8 |
TAT-NR2B9cb | H-GRKKRRQRRR-KLSSIESDV-OH | 19: 6 | 7 |
JNKI-1-TATDc | H-tdqsrpvqpflnlttprkprpp-rrrqrrkkrG-NH2 | 32: 9 | 12 |
TAT-JNKI-1c | H- GRKKRRQRRR-PPRPKRPTTLNLFPQVPRSQDT-OH | 32: 9 | 11 |
kFGF-JNKI-1 | H-AAVALLPAVLLALLAP-PPRPKRPTTLNLFPQVPRSQDT-OH | 38: 3 | 3 |
kFGFd | H-AAVALLPAVLLALLAP-OH | 16: 0 | 0 |
PYC36-TATe | H-GRKKRRQRRR-GGLQGRRRQGYQSIKP-NH2 | 26: 9 | 13 |
NCXBP3f | H-RRERRRRSCAGCSRARGSCRSCRR-NH2 | 24: 11 | 10.8 |
XIPg | H-RRLLFYKYVYKRYRAGKQRG-OH | 20: 5 | 8 |
BEN0254h | Ac-WGCCGRSSRRRRTR-NH2 | 14: 6 | 5.9 |
BEN0540h | Ac-PFLKRVPACLRLRR-NH2 | 14: 4 | 5 |
BEN1079h | Ac-RCGRASRCRVRWMRRRRI-NH2 | 18: 8 | 8.9 |
At the N terminus, H indicates free amine, and Ac indicates acetyl. At the C terminus, OH indicates free acid and NH2 indicates amide. Lower case single-letter code indicates D-isoform of the amino acid (AA).
Peptide described in Ho et al.12
NR2B9c-TAT peptide described by Aarts et al.6
Peptide described in Borsello et al.37
Peptide described in Lin et al.14
Peptide isolated by JLC from phylomer library (Phylogica Pty Ltd).
XIP described by He et al.38
Peptides isolated by Phylogica Pty Ltd.